MOLECULAR THERAPY
cod. 1000221

Academic year 2019/20
1° year of course - Second semester
Professor
Nicola GIULIANI
Academic discipline
Malattie del sangue (MED/15)
Field
Discipline medico-chirurgiche e riproduzione umana
Type of training activity
Characterising
42 hours
of face-to-face activities
6 credits
hub: PARMA
course unit
in ITALIAN

Learning objectives

the student should possess basic notions on the pathophysiology of the hematopoietic system and of the oncogenetic and infective process. The knowledge of conventional and innovative diagnostic and therapeutic strategies is also required. Moreover, the student should achieve the principles of stem cell therapy to treat hemato-oncologic diseases.

Prerequisites

- - -

Course unit content

basic knowledge on hematopoietic function and major hemathologic diseases

Full programme

Pathophysiology of the hematopoietic system
Stem cells and bone marrow transplantation
The student should aquire the basic knowledge on the pathogenesis of following conditions:
Anemias, thrombocytopenias, neutropenia;
Myelodysplastic syndromes;
Acute Leukemias;
Myeloproliferative diseases;
Monoclonal gammopathies and Multiple Myeloma;
bone marrow transplantation;
conventional and targeted anticancer therapy;
roles and functions of oncoproteins;
MAPK, AKT, STAT3, p53, p73, NF-kB PML and c-Abl signaling pathways;
cell cicle; Apoptosis; necrosis; myeloid differentiation;additive synergistic antagonistic pharmacological interactions between two or more drugs

Bibliography

1) Slides of the lectures; 2) Scientific papers from international bibliography.

Teaching methods

lectures with slide show; laboratory exercises.

Assessment methods and criteria

oral test

Other information

All the slides presented during the formal lessons and laboratory exercises will be available.

2030 agenda goals for sustainable development

- - -